Countdown to Ethereum Pectra Upgrade Activation: Learn more
$3.02T
Total marketcap
$150.76B
Total volume
BTC 61.35%     ETH 7.12%
Dominance

Viatris VTRS Stock

7.83 USD {{ price }} 1.811442% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
9.35B USD
LOW - HIGH [24H]
7.82 - 8.1 USD
VOLUME [24H]
5.82M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.53 USD

Viatris Price Chart

Viatris VTRS Financial and Trading Overview

Viatris stock price 7.83 USD
Previous Close 9.87 USD
Open 9.84 USD
Bid 9.86 USD x 4000
Ask 9.87 USD x 1400
Day's Range 9.82 - 9.89 USD
52 Week Range 8.74 - 12.4 USD
Volume 1.07M USD
Avg. Volume 8.9M USD
Market Cap 11.81B USD
Beta (5Y Monthly) 1.14
PE Ratio (TTM) 6.519868
EPS (TTM) -0.53 USD
Forward Dividend & Yield 0.48 (4.86%)
Ex-Dividend Date November 22, 2023
1y Target Est 14.11 USD

VTRS Valuation Measures

Enterprise Value 29.08B USD
Trailing P/E 6.519868
Forward P/E 3.5160716
PEG Ratio (5 yr expected) -1.32
Price/Sales (ttm) 0.76367885
Price/Book (mrq) 0.56603235
Enterprise Value/Revenue 1.88
Enterprise Value/EBITDA 5.895

Trading Information

Viatris Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 12.4 USD
52 Week Low 8.74 USD
50-Day Moving Average 9.34 USD
200-Day Moving Average 9.83 USD

VTRS Share Statistics

Avg. Volume (3 month) 8.9M USD
Avg. Daily Volume (10-Days) 8.44M USD
Shares Outstanding 1.2B
Float 1.2B
Short Ratio 3.79
% Held by Insiders 0.32%
% Held by Institutions 80.31%
Shares Short 32.33M
Short % of Float 3.08%
Short % of Shares Outstanding 2.68%

Dividends & Splits

Trailing Annual Dividend Rate 0.48
Trailing Annual Dividend Yield 4.86%
5 Year Average Dividend Yield 89.00%
Payout Ratio 0.3179
Last Split Factor 3:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) September 30, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 11.84%
Operating Margin (ttm) 14.63%
Gross Margin 42.92%
EBITDA Margin 31.89%

Management Effectiveness

Return on Assets (ttm) 2.74%
Return on Equity (ttm) 9.14%

Income Statement

Revenue (ttm) 15.47B USD
Revenue Per Share (ttm) 12.85 USD
Quarterly Revenue Growth (yoy) -3.30%
Gross Profit (ttm) 7.03B USD
EBITDA 4.93B USD
Net Income Avi to Common (ttm) 1.83B USD
Diluted EPS (ttm) 1.51
Quarterly Earnings Growth (yoy) -6.40%

Balance Sheet

Total Cash (mrq) 1.39B USD
Total Cash Per Share (mrq) 1.16 USD
Total Debt (mrq) 18.62B USD
Total Debt/Equity (mrq) 89.26 USD
Current Ratio (mrq) 1.6
Book Value Per Share (mrq) 17.393

Cash Flow Statement

Operating Cash Flow (ttm) 2.46B USD
Levered Free Cash Flow (ttm) 3.97B USD

Profile of Viatris

Country United States
State PA
City Canonsburg
Address 1000 Mylan Boulevard
ZIP 15317
Phone 724 514 1800
Website https://www.viatris.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 38000

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Q&A For Viatris Stock

What is a current VTRS stock price?

Viatris VTRS stock price today per share is 7.83 USD.

How to purchase Viatris stock?

You can buy VTRS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Viatris?

The stock symbol or ticker of Viatris is VTRS.

Which industry does the Viatris company belong to?

The Viatris industry is Drug Manufacturers-Specialty & Generic.

How many shares does Viatris have in circulation?

The max supply of Viatris shares is 1.19B.

What is Viatris Price to Earnings Ratio (PE Ratio)?

Viatris PE Ratio is now.

What was Viatris earnings per share over the trailing 12 months (TTM)?

Viatris EPS is -0.53 USD over the trailing 12 months.

Which sector does the Viatris company belong to?

The Viatris sector is Healthcare.

Viatris VTRS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16813.55 USD
+3.15
5.59B USD 16660.19 USD 17029.86 USD 5.59B USD
S&P 500 (Yahoo.com) GSPC 5397.19 USD
+2.07
2.23B USD 5357.64 USD 5469.69 USD 2.23B USD
S&P 500 INDEX SPX 5398.23 USD
+2.09
2.16B USD 5357.64 USD 5469.69 USD 2.16B USD
NASDAQ Global Select Market Com NQGS 8192.98 USD
+2.81
8144.73 USD 8324.83 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
Stlmt ID NASDAQ Biotechnology NBX 4124.19 USD
+3.5
3927.42 USD 4124.19 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1304.45 USD
+0.16
1301.65 USD 1326.48 USD
Nasdaq Factor Family US Value I NQFFUSV 1666.09 USD
+0.61
1665.61 USD 1698.48 USD
Nasdaq Next Generation 100 Inde NGX 1131.99 USD
+2.2
1129.55 USD 1156.21 USD
NASDAQ Biotechnology NBI 4115.11 USD
+1.65
4101.26 USD 4187.02 USD
NASDAQ HealthCare IXHC 912.02 USD
+1.75
909.85 USD 929.8 USD
Dorsey Wright Momentum Plus Div DWAMY 1403.98 USD
+0.35
1399.14 USD 1434.77 USD
NASDAQ Q 50 NXTQ 756.17 USD
+2.46
753.15 USD 770.51 USD